The global Human Oral Vaccine market was valued at US$ 1484 million in 2023 and is anticipated to reach US$ 2261.9 million by 2030, witnessing a CAGR of 6.3% during the forecast period 2024-2030.

Human Oral Vaccine Market

Oral vaccines are safe and easy to administer and convenient for all ages. They have been successfully developed to protect from many infectious diseases acquired through oral transmission. Oral delivery of vaccines represents the most attractive mode of administration over other routes of delivery due to the fact that the oral vaccination is noninvasive, safe and simple to execute, showing good patient compliance and clinical practicality.

International organizations, such as the World Health Organization (WHO) and UNICEF, have been actively promoting and supporting vaccination programs, which has positively impacted the oral vaccine market.

Oral vaccines have been essential for travel vaccination, especially for diseases like cholera and typhoid, which are prevalent in certain regions.

Continued investment in research and development has led to the discovery of new oral vaccine candidates and improved formulations.

This report aims to provide a comprehensive presentation of the global market for Human Oral Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Oral Vaccine.

Report Scope

The Human Oral Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Oral Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Oral Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Human Oral Vaccine Market Report

Report Metric	Details
Report Name	Human Oral Vaccine Market
Accounted market size in 2023	US$ 1484 million
Forecasted market size in 2030	US$ 2261.9 million
CAGR	6.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Rotavirus Vaccine Cholera Vaccine Oral Polio Vaccine Other
Segment by Application	Child Aldult
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, Tiantan Biological, EuBiologics, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Oral Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Oral Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Human Oral Vaccine Market growing?

Ans: The Human Oral Vaccine Market witnessing a CAGR of 6.3% during the forecast period 2024-2030.

What is the Human Oral Vaccine Market size in 2030?

Ans: The Human Oral Vaccine Market size in 2030 will be US$ 2261.9 million.

Who are the main players in the Human Oral Vaccine Market report?

Ans: The main players in the Human Oral Vaccine Market are Merck, GSK, Sanofi, Lanzhou Institute, Serum Institute, Valneva, Shanghai United Cell, Bibcol, PaxVax, Vabiotech, Tiantan Biological, EuBiologics, Panacea Biotec Ltd, Bio-Med, Halfkin Bio-Pharmaceuticals

What are the Application segmentation covered in the Human Oral Vaccine Market report?

Ans: The Applications covered in the Human Oral Vaccine Market report are Child, Aldult

What are the Type segmentation covered in the Human Oral Vaccine Market report?

Ans: The Types covered in the Human Oral Vaccine Market report are Rotavirus Vaccine, Cholera Vaccine, Oral Polio Vaccine, Other

1 Human Oral Vaccine Market Overview

1.1 Product Overview and Scope of Human Oral Vaccine

1.2 Human Oral Vaccine Segment by Type

1.2.1 Global Human Oral Vaccine Market Value Comparison by Type (2024-2030)

1.2.2 Rotavirus Vaccine

1.2.3 Cholera Vaccine

1.2.4 Oral Polio Vaccine

1.2.5 Other

1.3 Human Oral Vaccine Segment by Application

1.3.1 Global Human Oral Vaccine Market Value by Application: (2024-2030)

1.3.2 Child

1.3.3 Aldult

1.4 Global Human Oral Vaccine Market Size Estimates and Forecasts

1.4.1 Global Human Oral Vaccine Revenue 2019-2030

1.4.2 Global Human Oral Vaccine Sales 2019-2030

1.4.3 Global Human Oral Vaccine Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Human Oral Vaccine Market Competition by Manufacturers

2.1 Global Human Oral Vaccine Sales Market Share by Manufacturers (2019-2024)

2.2 Global Human Oral Vaccine Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Human Oral Vaccine Average Price by Manufacturers (2019-2024)

2.4 Global Human Oral Vaccine Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Human Oral Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Human Oral Vaccine, Product Type & Application

2.7 Human Oral Vaccine Market Competitive Situation and Trends

2.7.1 Human Oral Vaccine Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Human Oral Vaccine Players Market Share by Revenue

2.7.3 Global Human Oral Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Human Oral Vaccine Retrospective Market Scenario by Region

3.1 Global Human Oral Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Human Oral Vaccine Global Human Oral Vaccine Sales by Region: 2019-2030

3.2.1 Global Human Oral Vaccine Sales by Region: 2019-2024

3.2.2 Global Human Oral Vaccine Sales by Region: 2025-2030

3.3 Global Human Oral Vaccine Global Human Oral Vaccine Revenue by Region: 2019-2030

3.3.1 Global Human Oral Vaccine Revenue by Region: 2019-2024

3.3.2 Global Human Oral Vaccine Revenue by Region: 2025-2030

3.4 North America Human Oral Vaccine Market Facts & Figures by Country

3.4.1 North America Human Oral Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Human Oral Vaccine Sales by Country (2019-2030)

3.4.3 North America Human Oral Vaccine Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Human Oral Vaccine Market Facts & Figures by Country

3.5.1 Europe Human Oral Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Human Oral Vaccine Sales by Country (2019-2030)

3.5.3 Europe Human Oral Vaccine Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Human Oral Vaccine Market Facts & Figures by Country

3.6.1 Asia Pacific Human Oral Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Human Oral Vaccine Sales by Country (2019-2030)

3.6.3 Asia Pacific Human Oral Vaccine Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Human Oral Vaccine Market Facts & Figures by Country

3.7.1 Latin America Human Oral Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Human Oral Vaccine Sales by Country (2019-2030)

3.7.3 Latin America Human Oral Vaccine Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Human Oral Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Human Oral Vaccine Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Human Oral Vaccine Sales by Country (2019-2030)

3.8.3 Middle East and Africa Human Oral Vaccine Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Human Oral Vaccine Sales by Type (2019-2030)

4.1.1 Global Human Oral Vaccine Sales by Type (2019-2024)

4.1.2 Global Human Oral Vaccine Sales by Type (2025-2030)

4.1.3 Global Human Oral Vaccine Sales Market Share by Type (2019-2030)

4.2 Global Human Oral Vaccine Revenue by Type (2019-2030)

4.2.1 Global Human Oral Vaccine Revenue by Type (2019-2024)

4.2.2 Global Human Oral Vaccine Revenue by Type (2025-2030)

4.2.3 Global Human Oral Vaccine Revenue Market Share by Type (2019-2030)

4.3 Global Human Oral Vaccine Price by Type (2019-2030)

5 Segment by Application

5.1 Global Human Oral Vaccine Sales by Application (2019-2030)

5.1.1 Global Human Oral Vaccine Sales by Application (2019-2024)

5.1.2 Global Human Oral Vaccine Sales by Application (2025-2030)

5.1.3 Global Human Oral Vaccine Sales Market Share by Application (2019-2030)

5.2 Global Human Oral Vaccine Revenue by Application (2019-2030)

5.2.1 Global Human Oral Vaccine Revenue by Application (2019-2024)

5.2.2 Global Human Oral Vaccine Revenue by Application (2025-2030)

5.2.3 Global Human Oral Vaccine Revenue Market Share by Application (2019-2030)

5.3 Global Human Oral Vaccine Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Corporation Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Human Oral Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Merck Human Oral Vaccine Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 GSK

6.2.1 GSK Corporation Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Human Oral Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.2.4 GSK Human Oral Vaccine Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Sanofi

6.3.1 Sanofi Corporation Information

6.3.2 Sanofi Description and Business Overview

6.3.3 Sanofi Human Oral Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Sanofi Human Oral Vaccine Product Portfolio

6.3.5 Sanofi Recent Developments/Updates

6.4 Lanzhou Institute

6.4.1 Lanzhou Institute Corporation Information

6.4.2 Lanzhou Institute Description and Business Overview

6.4.3 Lanzhou Institute Human Oral Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Lanzhou Institute Human Oral Vaccine Product Portfolio

6.4.5 Lanzhou Institute Recent Developments/Updates

6.5 Serum Institute

6.5.1 Serum Institute Corporation Information

6.5.2 Serum Institute Description and Business Overview

6.5.3 Serum Institute Human Oral Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Serum Institute Human Oral Vaccine Product Portfolio

6.5.5 Serum Institute Recent Developments/Updates

6.6 Valneva

6.6.1 Valneva Corporation Information

6.6.2 Valneva Description and Business Overview

6.6.3 Valneva Human Oral Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Valneva Human Oral Vaccine Product Portfolio

6.6.5 Valneva Recent Developments/Updates

6.7 Shanghai United Cell

6.6.1 Shanghai United Cell Corporation Information

6.6.2 Shanghai United Cell Description and Business Overview

6.6.3 Shanghai United Cell Human Oral Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Shanghai United Cell Human Oral Vaccine Product Portfolio

6.7.5 Shanghai United Cell Recent Developments/Updates

6.8 Bibcol

6.8.1 Bibcol Corporation Information

6.8.2 Bibcol Description and Business Overview

6.8.3 Bibcol Human Oral Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.8.4 Bibcol Human Oral Vaccine Product Portfolio

6.8.5 Bibcol Recent Developments/Updates

6.9 PaxVax

6.9.1 PaxVax Corporation Information

6.9.2 PaxVax Description and Business Overview

6.9.3 PaxVax Human Oral Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.9.4 PaxVax Human Oral Vaccine Product Portfolio

6.9.5 PaxVax Recent Developments/Updates

6.10 Vabiotech

6.10.1 Vabiotech Corporation Information

6.10.2 Vabiotech Description and Business Overview

6.10.3 Vabiotech Human Oral Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Vabiotech Human Oral Vaccine Product Portfolio

6.10.5 Vabiotech Recent Developments/Updates

6.11 Tiantan Biological

6.11.1 Tiantan Biological Corporation Information

6.11.2 Tiantan Biological Human Oral Vaccine Description and Business Overview

6.11.3 Tiantan Biological Human Oral Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.11.4 Tiantan Biological Human Oral Vaccine Product Portfolio

6.11.5 Tiantan Biological Recent Developments/Updates

6.12 EuBiologics

6.12.1 EuBiologics Corporation Information

6.12.2 EuBiologics Human Oral Vaccine Description and Business Overview

6.12.3 EuBiologics Human Oral Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.12.4 EuBiologics Human Oral Vaccine Product Portfolio

6.12.5 EuBiologics Recent Developments/Updates

6.13 Panacea Biotec Ltd

6.13.1 Panacea Biotec Ltd Corporation Information

6.13.2 Panacea Biotec Ltd Human Oral Vaccine Description and Business Overview

6.13.3 Panacea Biotec Ltd Human Oral Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.13.4 Panacea Biotec Ltd Human Oral Vaccine Product Portfolio

6.13.5 Panacea Biotec Ltd Recent Developments/Updates

6.14 Bio-Med

6.14.1 Bio-Med Corporation Information

6.14.2 Bio-Med Human Oral Vaccine Description and Business Overview

6.14.3 Bio-Med Human Oral Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.14.4 Bio-Med Human Oral Vaccine Product Portfolio

6.14.5 Bio-Med Recent Developments/Updates

6.15 Halfkin Bio-Pharmaceuticals

6.15.1 Halfkin Bio-Pharmaceuticals Corporation Information

6.15.2 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Description and Business Overview

6.15.3 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales, Revenue and Gross Margin (2019-2024)

6.15.4 Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product Portfolio

6.15.5 Halfkin Bio-Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Human Oral Vaccine Industry Chain Analysis

7.2 Human Oral Vaccine Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Human Oral Vaccine Production Mode & Process

7.4 Human Oral Vaccine Sales and Marketing

7.4.1 Human Oral Vaccine Sales Channels

7.4.2 Human Oral Vaccine Distributors

7.5 Human Oral Vaccine Customers

8 Human Oral Vaccine Market Dynamics

8.1 Human Oral Vaccine Industry Trends

8.2 Human Oral Vaccine Market Drivers

8.3 Human Oral Vaccine Market Challenges

8.4 Human Oral Vaccine Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Halfkin Bio-Pharmaceuticals

List of Tables

Table 1. Global Human Oral Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Human Oral Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Human Oral Vaccine Market Competitive Situation by Manufacturers in 2023

Table 4. Global Human Oral Vaccine Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Human Oral Vaccine Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Human Oral Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Human Oral Vaccine Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Human Oral Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Human Oral Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Human Oral Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Human Oral Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Human Oral Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Human Oral Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Oral Vaccine as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Human Oral Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Human Oral Vaccine Sales by Region (2019-2024) & (K Units)

Table 18. Global Human Oral Vaccine Sales Market Share by Region (2019-2024)

Table 19. Global Human Oral Vaccine Sales by Region (2025-2030) & (K Units)

Table 20. Global Human Oral Vaccine Sales Market Share by Region (2025-2030)

Table 21. Global Human Oral Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Human Oral Vaccine Revenue Market Share by Region (2019-2024)

Table 23. Global Human Oral Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Human Oral Vaccine Revenue Market Share by Region (2025-2030)

Table 25. North America Human Oral Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Human Oral Vaccine Sales by Country (2019-2024) & (K Units)

Table 27. North America Human Oral Vaccine Sales by Country (2025-2030) & (K Units)

Table 28. North America Human Oral Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Human Oral Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Human Oral Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Human Oral Vaccine Sales by Country (2019-2024) & (K Units)

Table 32. Europe Human Oral Vaccine Sales by Country (2025-2030) & (K Units)

Table 33. Europe Human Oral Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Human Oral Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Human Oral Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Human Oral Vaccine Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Human Oral Vaccine Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Human Oral Vaccine Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Human Oral Vaccine Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Human Oral Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Human Oral Vaccine Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Human Oral Vaccine Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Human Oral Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Human Oral Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Human Oral Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Human Oral Vaccine Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Human Oral Vaccine Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Human Oral Vaccine Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Human Oral Vaccine Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Human Oral Vaccine Sales (K Units) by Type (2019-2024)

Table 51. Global Human Oral Vaccine Sales (K Units) by Type (2025-2030)

Table 52. Global Human Oral Vaccine Sales Market Share by Type (2019-2024)

Table 53. Global Human Oral Vaccine Sales Market Share by Type (2025-2030)

Table 54. Global Human Oral Vaccine Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Human Oral Vaccine Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Human Oral Vaccine Revenue Market Share by Type (2019-2024)

Table 57. Global Human Oral Vaccine Revenue Market Share by Type (2025-2030)

Table 58. Global Human Oral Vaccine Price (US$/Unit) by Type (2019-2024)

Table 59. Global Human Oral Vaccine Price (US$/Unit) by Type (2025-2030)

Table 60. Global Human Oral Vaccine Sales (K Units) by Application (2019-2024)

Table 61. Global Human Oral Vaccine Sales (K Units) by Application (2025-2030)

Table 62. Global Human Oral Vaccine Sales Market Share by Application (2019-2024)

Table 63. Global Human Oral Vaccine Sales Market Share by Application (2025-2030)

Table 64. Global Human Oral Vaccine Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Human Oral Vaccine Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Human Oral Vaccine Revenue Market Share by Application (2019-2024)

Table 67. Global Human Oral Vaccine Revenue Market Share by Application (2025-2030)

Table 68. Global Human Oral Vaccine Price (US$/Unit) by Application (2019-2024)

Table 69. Global Human Oral Vaccine Price (US$/Unit) by Application (2025-2030)

Table 70. Merck Corporation Information

Table 71. Merck Description and Business Overview

Table 72. Merck Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Merck Human Oral Vaccine Product

Table 74. Merck Recent Developments/Updates

Table 75. GSK Corporation Information

Table 76. GSK Description and Business Overview

Table 77. GSK Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. GSK Human Oral Vaccine Product

Table 79. GSK Recent Developments/Updates

Table 80. Sanofi Corporation Information

Table 81. Sanofi Description and Business Overview

Table 82. Sanofi Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Sanofi Human Oral Vaccine Product

Table 84. Sanofi Recent Developments/Updates

Table 85. Lanzhou Institute Corporation Information

Table 86. Lanzhou Institute Description and Business Overview

Table 87. Lanzhou Institute Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Lanzhou Institute Human Oral Vaccine Product

Table 89. Lanzhou Institute Recent Developments/Updates

Table 90. Serum Institute Corporation Information

Table 91. Serum Institute Description and Business Overview

Table 92. Serum Institute Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Serum Institute Human Oral Vaccine Product

Table 94. Serum Institute Recent Developments/Updates

Table 95. Valneva Corporation Information

Table 96. Valneva Description and Business Overview

Table 97. Valneva Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Valneva Human Oral Vaccine Product

Table 99. Valneva Recent Developments/Updates

Table 100. Shanghai United Cell Corporation Information

Table 101. Shanghai United Cell Description and Business Overview

Table 102. Shanghai United Cell Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. Shanghai United Cell Human Oral Vaccine Product

Table 104. Shanghai United Cell Recent Developments/Updates

Table 105. Bibcol Corporation Information

Table 106. Bibcol Description and Business Overview

Table 107. Bibcol Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. Bibcol Human Oral Vaccine Product

Table 109. Bibcol Recent Developments/Updates

Table 110. PaxVax Corporation Information

Table 111. PaxVax Description and Business Overview

Table 112. PaxVax Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. PaxVax Human Oral Vaccine Product

Table 114. PaxVax Recent Developments/Updates

Table 115. Vabiotech Corporation Information

Table 116. Vabiotech Description and Business Overview

Table 117. Vabiotech Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Vabiotech Human Oral Vaccine Product

Table 119. Vabiotech Recent Developments/Updates

Table 120. Tiantan Biological Corporation Information

Table 121. Tiantan Biological Description and Business Overview

Table 122. Tiantan Biological Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 123. Tiantan Biological Human Oral Vaccine Product

Table 124. Tiantan Biological Recent Developments/Updates

Table 125. EuBiologics Corporation Information

Table 126. EuBiologics Description and Business Overview

Table 127. EuBiologics Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 128. EuBiologics Human Oral Vaccine Product

Table 129. EuBiologics Recent Developments/Updates

Table 130. Panacea Biotec Ltd Corporation Information

Table 131. Panacea Biotec Ltd Description and Business Overview

Table 132. Panacea Biotec Ltd Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 133. Panacea Biotec Ltd Human Oral Vaccine Product

Table 134. Panacea Biotec Ltd Recent Developments/Updates

Table 135. Bio-Med Corporation Information

Table 136. Bio-Med Description and Business Overview

Table 137. Bio-Med Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 138. Bio-Med Human Oral Vaccine Product

Table 139. Bio-Med Recent Developments/Updates

Table 140. Halfkin Bio-Pharmaceuticals Corporation Information

Table 141. Halfkin Bio-Pharmaceuticals Description and Business Overview

Table 142. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 143. Halfkin Bio-Pharmaceuticals Human Oral Vaccine Product

Table 144. Halfkin Bio-Pharmaceuticals Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Human Oral Vaccine Distributors List

Table 148. Human Oral Vaccine Customers List

Table 149. Human Oral Vaccine Market Trends

Table 150. Human Oral Vaccine Market Drivers

Table 151. Human Oral Vaccine Market Challenges

Table 152. Human Oral Vaccine Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Human Oral Vaccine

Figure 2. Global Human Oral Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Human Oral Vaccine Market Share by Type in 2023 & 2030

Figure 4. Rotavirus Vaccine Product Picture

Figure 5. Cholera Vaccine Product Picture

Figure 6. Oral Polio Vaccine Product Picture

Figure 7. Other Product Picture

Figure 8. Global Human Oral Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Human Oral Vaccine Market Share by Application in 2023 & 2030

Figure 10. Child

Figure 11. Aldult

Figure 12. Global Human Oral Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Human Oral Vaccine Market Size (2019-2030) & (US$ Million)

Figure 14. Global Human Oral Vaccine Sales (2019-2030) & (K Units)

Figure 15. Global Human Oral Vaccine Average Price (US$/Unit) & (2019-2030)

Figure 16. Human Oral Vaccine Report Years Considered

Figure 17. Human Oral Vaccine Sales Share by Manufacturers in 2023

Figure 18. Global Human Oral Vaccine Revenue Share by Manufacturers in 2023

Figure 19. The Global 5 and 10 Largest Human Oral Vaccine Players: Market Share by Revenue in 2023

Figure 20. Human Oral Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 21. Global Human Oral Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 22. North America Human Oral Vaccine Sales Market Share by Country (2019-2030)

Figure 23. North America Human Oral Vaccine Revenue Market Share by Country (2019-2030)

Figure 24. United States Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 25. Canada Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Europe Human Oral Vaccine Sales Market Share by Country (2019-2030)

Figure 27. Europe Human Oral Vaccine Revenue Market Share by Country (2019-2030)

Figure 28. Germany Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 29. France Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. U.K. Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. Italy Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Russia Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Asia Pacific Human Oral Vaccine Sales Market Share by Region (2019-2030)

Figure 34. Asia Pacific Human Oral Vaccine Revenue Market Share by Region (2019-2030)

Figure 35. China Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 36. Japan Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. South Korea Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. India Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. Australia Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. China Taiwan Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. Indonesia Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Thailand Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Malaysia Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Latin America Human Oral Vaccine Sales Market Share by Country (2019-2030)

Figure 45. Latin America Human Oral Vaccine Revenue Market Share by Country (2019-2030)

Figure 46. Mexico Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 47. Brazil Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Argentina Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Middle East & Africa Human Oral Vaccine Sales Market Share by Country (2019-2030)

Figure 50. Middle East & Africa Human Oral Vaccine Revenue Market Share by Country (2019-2030)

Figure 51. Turkey Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 52. Saudi Arabia Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. UAE Human Oral Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. Global Sales Market Share of Human Oral Vaccine by Type (2019-2030)

Figure 55. Global Revenue Market Share of Human Oral Vaccine by Type (2019-2030)

Figure 56. Global Human Oral Vaccine Price (US$/Unit) by Type (2019-2030)

Figure 57. Global Sales Market Share of Human Oral Vaccine by Application (2019-2030)

Figure 58. Global Revenue Market Share of Human Oral Vaccine by Application (2019-2030)

Figure 59. Global Human Oral Vaccine Price (US$/Unit) by Application (2019-2030)

Figure 60. Human Oral Vaccine Value Chain

Figure 61. Human Oral Vaccine Production Process

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Distributors Profiles

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions